Loading data for CANC — first visit, this takes a few seconds.
Tema Oncology ETF (CANC)
NasdaqGM: CANC
· Prix en temps réel · USD
44.99
+1.25 (2.86%)
À la clôture : Aug 19, 2026, 3:26 PM
Tema Oncology ETF (CANC) ETF Price, Holdings & Analysis
2.86% (1D)
Aucune donnée disponible
| Bid | 41.61 |
| Capitalisation boursière | n/a |
| AUM | 193.31M |
| NAV | 43.15 |
| Bêta | n / A |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 28.30 |
| Parts en circulation | n / A |
| Date de création | Aug 14, 2023 |
| Ask | 42.11 |
| Volume | 12,595 |
| Moy. Volume (20D) | 32,220 |
| Ouverture | 44.84 |
| Clôture précédente | 43.74 |
| Fourchette du jour | 44.59 - 45.35 |
| Intervalle de 52 semaines | 26.24 - 45.35 |
| Positions | n / A |
| Ratio de frais | 0.75% |
À propos de CANC
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Classe d’actifs Equity
Symbole boursier CANC
Date de création Aug 14, 2023
Fournisseur Tema Etfs
Site web Page d’accueil du fonds
Échange NasdaqGM
10 principaux titres 42.56% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Revolution Medicines... | RVMD | 6.14% |
| Cogent Biosciences I... | COGT | 5.31% |
| Eli Lilly And Co | LLY | 5.22% |
| Roche Holding Ag Adr | RHHBY | 4.65% |
| Novartis Ag Register... | NOVN.SW | 4.16% |
| Bristol-myers Squibb... | BMY | 3.73% |
| Abbvie Inc | ABBV | 3.72% |
| Merck & Co Inc | MRK | 3.65% |
| Johnson & Johnson | JNJ | 3.13% |
| Immunome Inc Ordinar... | IMNM | 2.85% |
Dividendes Rendement du dividende 0.04%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Dec 10, 2025 | $0.0200 | n / A |
| Dec 11, 2024 | $0.7280 | n / A |
| Dec 13, 2023 | $0.1490 | n / A |
